Even though few in vitro studies pointed out a detrimental role of BET inhibition in AD pathology [146], a growing body of evidence underlines that BET blockade could counteract cognitive dysfunction and neuroinflammation in different cellular and animal models [23,143,145]. This evidence concerns the gene DNER and Alzheimer disease.